Sally E. Wenzel MD
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma (NCT04743791) | Sally E. Wenzel MD | 2022-10-17 |
Track Sally E. Wenzel MD automatically
Every clearance here is in the API, with alerts when new ones post.